Sialic Acids Content Analysis of the Innovator and Biosimilar Darbepoetin Alfa by Fluorometric HPLC Assay

Author(s): Yanyan Huo, Jinjiao He, Feng Li*

Journal Name: Current Pharmaceutical Analysis

Volume 15 , Issue 4 , 2019


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Erythropoietin is a highly glycosylated protein hormone, used medically for the treatment of anemia associated with chronic renal disease. Due to patent expirations, we expect biosimilar erythropoietins to play an increasing role in healthcare in coming years.

Objective: Here, we have developed a chromatograpy method for determination of Neu5AC and Neu5Gc in darbepoetin alfa.

Methods: Sialic acids (Sias) analysis provides the contents of the two most abundant sialic acids Neu5Ac and Neu5Gc. It has often been utilized for the evaluation of sialylated glycoprotein to ensure the biopharmtherapeutic safety and efficacy. In this work, the application of the DMB derivatization of Sias from darbepoetin alfa followed by the separation of the resulting adducts based on HPLC-FLD was presented.

Results: Our work demonstrated that the method is characteristics of simple operation, and high reproducibility and sensitivity, and easy to set up for compliance analysis in a routine laboratory.

Conclusion: By using a water:acetonitrile gradient, high resolution of Sias was obtained within a 1 min analysis time. The detection limits of NeuAc and NeuGc were 2.9 µg/L and 1.5 µg/L, respectively. The RSDs of the intraday and interday precisions in terms of retention time and peak areas of the analytes are below 1%, and from 3.8% to 4.2% respectively. Therefore, this developed method can be widely applied for simple determination of Neu5Ac, Neu5Gc, and O-acetylated Sias in the derivatized samples. Especially, high levels of O-acetylation were detected on darbepoetin alfa N-glycans, which are critical to establishing the bioequivalence of darbepoetin alfa biosimilars.

Keywords: Sialic acids, high performance liquid chromatography, 1, 2-diamino-4, 5-methylenedioxybenzene dihydrochloride, Darbepoetin alfa.

[1]
Sato, C.; Kitajima, K. Disialic, oligosialic and polysialic acids: distribution, functions and related disease. J. Biochem., 2013, 154(2), 115-136.
[2]
Inoue, S.; Kanamori, A.; Kitajima, K.; Inoue, Y. KDN-glycoprotein: a novel deaminated neuraminic acid-rich glycoprotein isolated from vitelline envelope of rainbow trout eggs. Biochem. Biophys. Res. Commun., 1988, 153, 172-176.
[3]
Nguyen, D.H.; Tangvoranuntakul, P.; Varki, A. Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells. J. Immunol., 2005, 175(1), 228-236.
[4]
Lu, Q.; Padler-Karavani, V.; Yu, H.; Chen, X.; Wu, S.L.; Varki, A.; Hancock, W.S. LC-MS analysis of polyclonal human anti-Neu5Gc Xeno-autoantibodies IgG subclass and partial sequence using multi-step IVIG affinity purification and multi-enzymatic digestion. Anal. Chem., 2012, 84(6), 2761-2768.
[5]
Anshu, K.; Narendra, C.; Pradip, N. Immunogenicity of biotherapeutics: causes and association with posttranslational modifications. J. Immunol. Res., 2016, 10, 1-18.
[6]
Maeda, E.; Kita, S.; Kinoshita, M.; Urakami, K.; Hayakawa, T.; Kakehi, K. Analysis of nonhuman N-glycans as the minor constituents in recombinant monoclonal antibody pharmaceuticals. Anal. Chem., 2012, 84(5), 2373-2379.
[7]
Krantz, S.B. Erythropoietin. Blood, 1991, 77, 419-434.
[8]
Winearls, C.G. Recombinant human erythropoietin: 10 years of clinical experience. Nephrol. Dial. Transplant., 1998, 13(Suppl. 2), 3-8.
[9]
Agoram, B.; Aoki, K.; Doshi, S.; Gegg, C.; Jang, G.; Molineux, G.; Narhi, L.; Elliott, S. Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: nonerythropoietin receptor-mediated pathways may play a major role. J. Pharm. Sci., 2009, 98, 2198-2211.
[10]
Delorme, E.; Lorenzini, T.; Giffin, J.; Martin, F.; Jacobsen, F.; Boone, T.; Elliott, S. Role of glycosylation on the secretion and biological activity of erythropoietin. Biochemistry, 1992, 31, 9871-9876.
[11]
Bones, J.; McLoughlin, N.; Hilliard, M.; Wynne, K.; Karger, B.L. Rudd P.M. 2D-LC analysis of BRP 3 erythropoietin N-glycosylation using anion exchange fractionation and hydrophilic interaction UPLC reveals long poly-N-acetyl lactosamine extensions. Anal. Chem., 2011, 83, 4154-4162.
[12]
Jelkmann, W. Biosimilar recombinant human erythropoietins (“epoetins”) and future erythropoiesis-stimulating treatments. Expert Opin. Biol. Ther., 2012, 12(5), 581-592.
[13]
Lacomba, R.; Salcedo, J.; Alegría, A.; Lagarda, M.; Barberá, R.; Matencio, E. Determination of sialic acid and gangliosides in biological samples and dairy products: A review. J. Pharm. Biomed. Anal., 2010, 51, 346-357.
[14]
Yao, H.L.; Conway, L.P.; Wang, M.M.; Huang, K.; Liu, L.; Voglmeir, J. Quantification of sialic acids in red meat by UPLC-FLD using indoxylsialosides as internal standards. Glycoconj. J., 2016, 33(2), 219-226.
[15]
Szabo, Z.; Bones, J.; Guttman, A.; Glick, J.; Karger, B.L. Sialic acid speciation using capillary electrophoresis: optimization of analyte derivatization and separation. Anal. Chem., 2012, 84, 7638-7642.
[16]
Wang, D.; Zhou, X.; Wang, L.; Wang, S.; Sun, X.L. Quantification of free sialic acid in human plasma through a robust quinoxalinone derivatization and LC-MS/MS using isotope-labeled standard calibration. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2014, 944, 75-81.
[17]
Hara, S.; Takemori, Y.; Yamaguchi, M.; Nakamura, M.; Ohkura, Y. Fluorometric high-performance liquid chromatography of N-acetyl- and N-glycolyl- neuraminic acids and its application to their microdetermination in human and animal sera, glycoproteins, and glycolipids. Anal. Biochem., 1987, 164, 138-145.
[18]
Spichtig, V.; Michaud, J.; Austin, S. Determination of sialic acids in milks and milk-based products. Anal. Biochem., 2010, 405, 28-40.
[19]
Martín, M.J.; Vázquez, E.; Rueda, R. Application of a sensitive fluorometric HPLC assay to determine the sialic acid content of infant formulas. Anal. Bioanal. Chem., 2007, 387, 2943-2949.
[20]
Mandal, C.; Schwartz-Albiez, R.; Vlasak, R. Functions and biosynthesis of O-acetylated sialic acids. Top. Curr. Chem., 2015, 366, 1-30.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 4
Year: 2019
Published on: 19 March, 2019
Page: [333 - 337]
Pages: 5
DOI: 10.2174/1573412914666180427160327
Price: $65

Article Metrics

PDF: 43
HTML: 1